Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer
- 14 April 2006
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 13 (6) , 802-808
Abstract
Recent experimental evidence has shown a potential role of interleukin (IL)-11 and its receptor in breast cancer development and progression. However, there is little clinical information to support this hypothesis. We examined the expression of IL-11 and its receptor in primary breast cancer tissue samples and correlated their level of expression with the clinical outcome. Primary breast cancer samples (n=109) and matched background tissue obtained from patients in the cohort (n=33) were processed for frozen section and RNA extraction. Frozen sections from matched tissues were immunostained with IL-11 and IL-11 receptor antibodies. Staining intensity was analyzed by computer image analysis. RNA was reverse-transcribed and quantified before analysis by quantitative polymerase chain reaction. Results were expressed as the number of transcripts (standardized by beta-actin). The data were compared with the clinical outcome of the disease. The intensity of staining for both IL-11 and the IL-11 receptor was distinctly high in tumor samples (P<.01). The transcript level of IL-11 was significantly higher in node-positive tumor samples compared with node-negative samples (P=.02). Tumors with a poor prognostic index and poor histological grade showed a higher level of IL-11. A higher level of IL-11 was linked to poorer survival with Kaplan-Meier survival analysis. IL-11 can be a predictor of poor prognosis in human breast cancer.Keywords
This publication has 17 references indexed in Scilit:
- Breast cancer cells induce osteoclast formation by stimulating host IL‐11 production and downregulating granulocyte/macrophage colony‐stimulating factorInternational Journal of Cancer, 2004
- A multigenic program mediating breast cancer metastasis to boneCancer Cell, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Suppression of Interleukin-11-mediated bone resorption by cyclooxygenases inhibitorsJournal of Cellular Physiology, 1998
- Expression and function of members of the cytokine receptor superfamily on breast cancer cellsOncogene, 1997
- Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cellsMolecular and Cellular Endocrinology, 1996
- Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of OsteoporosisNew England Journal of Medicine, 1995
- Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burdenInternational Journal of Cancer, 1993
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991